• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.针对接受环丙沙星治疗的中性粒细胞减少患者的草绿色链球菌血培养分离株，潜在治疗性和预防性抗生素的活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2493-5. doi: 10.1128/AAC.37.11.2493.
2
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.八种大环内酯类抗生素及RP-59500（奎奴普丁-达福普汀）对从中性粒细胞减少的癌症患者血液中分离出的草绿色链球菌的体外活性。
Antimicrob Agents Chemother. 1996 Sep;40(9):2117-20. doi: 10.1128/AAC.40.9.2117.
3
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.从癌症中性粒细胞减少患者血液中分离出的草绿色链球菌的分子关系及抗菌药敏性
J Clin Microbiol. 1999 Jun;37(6):1876-80. doi: 10.1128/JCM.37.6.1876-1880.1999.
4
Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.中性粒细胞减少患者中引起败血症的链球菌属的抗菌药敏性。
Antimicrob Agents Chemother. 1989 Apr;33(4):580-2. doi: 10.1128/AAC.33.4.580.
5
Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001.
Acta Clin Belg. 2003 Mar-Apr;58(2):111-9.
6
Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.临床A、B、C、F和G组β溶血性链球菌分离株对24种抗菌药物的敏感性比较
Chemotherapy. 1997 Jan-Feb;43(1):10-20. doi: 10.1159/000239529.
7
Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.SCOPE项目中的医院获得性链球菌血流感染：菌种分布及抗菌药物耐药性。SCOPE医院研究小组。
Diagn Microbiol Infect Dis. 1997 Dec;29(4):259-63. doi: 10.1016/s0732-8893(97)00159-4.
8
Susceptibilities of streptococcal strains associated with infective endocarditis to nine antibiotics.
Chemotherapy. 1988;34(2):113-6. doi: 10.1159/000238557.
9
Antimicrobial susceptibility of viridans group streptococci.草绿色链球菌的抗菌药敏性。
Diagn Microbiol Infect Dis. 1997 Dec;29(4):277-80. doi: 10.1016/s0732-8893(97)00140-5.
10
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin.阿奇霉素或克拉霉素治疗患者正常咽喉菌群中草绿色链球菌的红霉素敏感性
Clin Microbiol Infect. 2002 Feb;8(2):85-92. doi: 10.1046/j.1469-0691.2002.00347.x.

引用本文的文献

1
In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study.一项加拿大全国性监测研究中头孢吡肟对多重耐药革兰阴性杆菌、草绿色链球菌和肺炎链球菌的体外活性
Can J Infect Dis. 1999 Mar;10(2):122-7. doi: 10.1155/1999/172031.
2
Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.利奈唑胺预防由口腔链球菌或粪肠球菌引起的实验性主动脉瓣心内膜炎。
Antimicrob Agents Chemother. 2006 Feb;50(2):654-7. doi: 10.1128/AAC.50.2.654-657.2006.
3
Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.2000年新型氟喹诺酮类、酮内酯类及其他抗菌药物对加拿大各地草绿色链球菌血培养分离株的活性。
Antimicrob Agents Chemother. 2002 May;46(5):1553-6. doi: 10.1128/AAC.46.5.1553-1556.2002.
4
Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.德国全国多中心研究：中性粒细胞减少患者链球菌血培养分离株的抗生素耐药性患病率以及奎奴普丁-达福普汀与其他八种抗菌药物的体外活性比较
J Clin Microbiol. 2001 May;39(5):1928-31. doi: 10.1128/JCM.39.5.1928-1931.2001.
5
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.从癌症中性粒细胞减少患者血液中分离出的草绿色链球菌的分子关系及抗菌药敏性
J Clin Microbiol. 1999 Jun;37(6):1876-80. doi: 10.1128/JCM.37.6.1876-1880.1999.
6
E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.用于草绿色链球菌抗菌药物敏感性试验的E试验与琼脂稀释法比较
J Clin Microbiol. 1999 Jan;37(1):26-30. doi: 10.1128/JCM.37.1.26-30.1999.
7
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.阿奇霉素或克拉霉素预防草绿色链球菌实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 1997 Aug;41(8):1673-6. doi: 10.1128/AAC.41.8.1673.
8
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.八种大环内酯类抗生素及RP-59500（奎奴普丁-达福普汀）对从中性粒细胞减少的癌症患者血液中分离出的草绿色链球菌的体外活性。
Antimicrob Agents Chemother. 1996 Sep;40(9):2117-20. doi: 10.1128/AAC.40.9.2117.
9
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.美国草绿色链球菌中出现高比例的抗菌药物耐药性。
Antimicrob Agents Chemother. 1996 Apr;40(4):891-4. doi: 10.1128/AAC.40.4.891.
10
Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution.对单一机构中288例中性粒细胞减少的癌症患者菌血症发作情况的前瞻性研究。
Eur J Clin Microbiol Infect Dis. 1996 Apr;15(4):291-6. doi: 10.1007/BF01695660.

本文引用的文献

1
Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.白血病中性粒细胞减少患者由草绿色链球菌引起的败血症。
Lancet. 1983;2(8365-66):1452-4. doi: 10.1016/s0140-6736(83)90799-7.
2
Resistance in oral streptococci after repeated three-dose erythromycin prophylaxis.重复三剂红霉素预防后口腔链球菌的耐药性。
J Antimicrob Chemother. 1985 Apr;15(4):471-9. doi: 10.1093/jac/15.4.471.
3
Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.在接受环丙沙星治疗的粒细胞减少患者中，罗红霉素（RU-28965）对预防α溶血性链球菌引起的菌血症的作用
Infection. 1989 Jul-Aug;17(4):240-4. doi: 10.1007/BF01639528.
4
Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.中性粒细胞减少患者中引起败血症的链球菌属的抗菌药敏性。
Antimicrob Agents Chemother. 1989 Apr;33(4):580-2. doi: 10.1128/AAC.33.4.580.
5
Adult respiratory distress syndrome in neutropenic leukemia patients.中性粒细胞减少性白血病患者的成人呼吸窘迫综合征
Blut. 1989 Jun;58(6):287-90. doi: 10.1007/BF00320168.
6
Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis.从接受氧氟沙星抗菌预防的急性白血病患者中分离出的草绿色链球菌的抗菌药敏性。
Infection. 1989 Nov-Dec;17(6):396-7. doi: 10.1007/BF01645556.
7
Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside.接受持续或大剂量间歇性阿糖胞苷治疗的白血病儿童中的甲型链球菌败血症。
Pediatr Infect Dis J. 1989 Nov;8(11):755-8. doi: 10.1097/00006454-198911000-00005.
8
Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.某白血病病房出现对环丙沙星高度耐药的凝固酶阴性葡萄球菌暴发。
BMJ. 1989 Jul 29;299(6694):294-7. doi: 10.1136/bmj.299.6694.294.
9
Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.接受强化化疗的成年白血病患者的链球菌菌血症。55例病例回顾。
Infection. 1990 May-Jun;18(3):138-45. doi: 10.1007/BF01642101.
10
Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin.接受阿糖胞苷治疗的患者因链球菌败血症引发呼吸衰竭，以及青霉素对其的预防作用。
Infection. 1990 May-Jun;18(3):131-7. doi: 10.1007/BF01642100.

针对接受环丙沙星治疗的中性粒细胞减少患者的草绿色链球菌血培养分离株，潜在治疗性和预防性抗生素的活性。

Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.

作者信息

McWhinney P H, Patel S, Whiley R A, Hardie J M, Gillespie S H, Kibbler C C

机构信息

Department of Microbiology, Royal Free Hospital School of Medicine, London, United Kingdom.

出版信息

Antimicrob Agents Chemother. 1993 Nov;37(11):2493-5. doi: 10.1128/AAC.37.11.2493.

DOI:10.1128/AAC.37.11.2493
PMID:8285642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC192417/
Abstract

All 47 sequential blood culture isolates of viridans group streptococci obtained from febrile neutropenic patients receiving quinolone prophylaxis were susceptible to vancomycin, teicoplanin, and imipenem. Resistance to benzylpenicillin (MIC for 50% of isolates [MIC50], 0.125 microgram/ml) and ceftazidime (MIC50, 4 micrograms/ml) was common. Most isolates were susceptible to amoxicillin, co-amoxiclav (amoxicillin-clavulanic acid at a 2:1 ratio by weight), azlocillin, clarithromycin, and erythromycin, with azithromycin showing comparable activity. The MIC90 of sparfloxacin was 1 microgram/ml; those for ciprofloxacin and ofloxacin were > 16 and 16 micrograms/ml, respectively.

摘要

从接受喹诺酮预防治疗的发热性中性粒细胞减少患者中获得的47株连续性草绿色链球菌血培养分离株，对万古霉素、替考拉宁和亚胺培南均敏感。对苄青霉素（50%分离株的MIC[MIC50]，0.125微克/毫升）和头孢他啶（MIC50，4微克/毫升）耐药很常见。大多数分离株对阿莫西林、阿莫西林克拉维酸（按重量比2:1的阿莫西林-克拉维酸）、阿洛西林、克拉霉素和红霉素敏感，阿奇霉素显示出相当的活性。司帕沙星的MIC90为1微克/毫升；环丙沙星和氧氟沙星的MIC90分别>16和16微克/毫升。